Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global DX was a private UK animal health diagnostics company focused on rapid lateral flow tests for veterinary use at the point of care. The company marketed diagnostic product lines for companion animals under the Petscreen brand and for livestock under the Herdscreen brand, with a particular emphasis on infectious disease testing and surveillance. Its offering appears to have included commercial veterinary rapid tests such as African swine fever and foot-and-mouth disease antibody assays, and it also promoted contract development and brand support services through Global DX Solutions. The business drew on experience associated with Omega Diagnostics founder Andrew Shepherd and positioned itself as a specialist in veterinary immunoassay and field-deployable diagnostics. Although its products were commercialized, the UK legal entity Global DX Limited is now in liquidation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global DX.